A9582 Iodine i-123 iobenguaneIodine i-123 iobenguane, diagnostic, per study dose, up to 15 millicuries
Status X: statutory exclusion, not paid under the PFS.
A9582 appears in 5 coverage policies from Aetna, Blue Cross & Blue Shield of Mississippi, Blue Shield of California, BlueCross BlueShield of South Carolina, Health Care Service Corporation (BCBS IL, TX, OK, NM, MT).
| Payer | Policy | Role in policy | Reviewed | Document |
|---|---|---|---|---|
| Aetna | Tumor Scintigraphy (0168) | covered if criteria are met | Mar 27, 2026 | payer document |
| Blue Cross & Blue Shield of Mississippi | Myocardial Sympathetic Innervation Imaging In Individuals With Heart Failure | unproven / investigational | payer document | |
| Blue Shield of California | Myocardial Sympathetic Innervation Imaging in Individuals With Heart Failure (6.01.56) | listed, no stance | payer document | |
| BlueCross BlueShield of South Carolina | Myocardial Sympathetic Innervation Imaging in Patients With Heart Failure (CAM 60156) | listed, no stance | Aug 1, 2026 | payer document |
| Health Care Service Corporation (BCBS IL, TX, OK, NM, MT) | Myocardial Sympathetic Innervation Imaging in Individuals With Heart Failure (RAD604.012) | listed, no stance | Nov 15, 2025 | payer document |
Prior authorization required or conditional in IN.
From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.